Functional geriatric assessment tests predict toxicity rates in functional high risk myeloma patients treated with daratumumab, carfilzomib, lenalidomide and dexamethasone in a prospective clinical trial Meeting Abstract
| Authors: | Shmuel, R.; Tellem, R.; Gatt, M. E.; Lavi, N.; Ganzel, C.; Luttwak, E.; Chubar, E.; Rouvio, O.; Vaxman, I.; Pasvolsky, O.; Ballan, M.; Tadmor, T.; Nemets, A.; Jarchowcky, O.; Shvetz, O.; Lieba, M.; Shpilberg, O.; Lowenton-Spier, N.; Dally, N.; Mazza, I. A.; Cohen, Y. C. |
| Abstract Title: | Functional geriatric assessment tests predict toxicity rates in functional high risk myeloma patients treated with daratumumab, carfilzomib, lenalidomide and dexamethasone in a prospective clinical trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 6965 |
| End Page: | 6966 |
| Language: | English |
| ACCESSION: | WOS:001415718800045 |
| DOI: | 10.1182/blood-2024-202392 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
